Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Xentria & Meitheal Pharmaceuticals Announce Exclusive Licensing Agreement For Xtmab-16 In North America
Thursday, June 29, 2023Xentria Inc a clinicalstage biotherapeutics company focused on developing therapeutics to address unmet clinical needs and Meitheal Pharmaceuticals Inc today announced an exclusive multiyear licensing agreement to commercialize its lead candidate and...
Tonix Pharmaceuticals Enters into Agreement to Acquire Two FDA-Approved, Marketed Migraine Products from Upsher-Smith Laboratories, LLC
Tuesday, June 27, 2023Tonix Pharmaceuticals Holding Corp Nasdaq TNXP Tonix Pharmaceuticals or Tonix and its whollyowned subsidiary Tonix Medicines Inc Tonix Medicines a clinicalstage biopharmaceutical company today announced that they have entered into an agreement to acq...
Productlife Group Announces Its Intent To Merge With Pharma D&s Group
Tuesday, June 27, 2023The ProductLife Group has taken an important step in its growth with the acquisition of the Italian private company Pharma DS Group With this strategic alliance PLG a global provider of regulation and compliance services for the life sciences industr...
Sobi completes acquisition of CTI BioPharma Corp.
Tuesday, June 27, 2023Swedish Orphan Biovitrum AB publ Sobi STOSOBI and CTI BioPharma Corp NASDAQCTIC CTI announced today the completion of the acquisition of CTI by Sobi through its indirect wholly owned subsidiary Cleopatra Acquisition Corp Cleopatra
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics
Tuesday, June 27, 2023ERYTECH Nasdaq Euronext ERYP and PHERECYDES announce merger and name change to PHAXIAM Therapeutics a clinicalstage biopharmaceutical company developing innovative extended bacteriophage therapies to target antimicrobial resistance AMR
Genomic Vision signs a distribution agreement with CliniSciences
Saturday, June 24, 2023Genomic Vision FR GV the Company a biotechnology company listed on Euronext developing products and services for the precise characterization of DNA sequences is pleased to announce an agreement exclusive European distribution with CliniSciences
IRBM Extends Peptide Therapeutics Collaboration with Merck & Co. Inc., Rahway NJ USA
Friday, June 23, 2023IRBM an innovative contract research organization today announced it has signed a new agreement with Merck Co Inc Rahway NJ USA known as MSD outside the USA and Canada to continue their collaboration in the peptide therapeutics area
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
Friday, June 23, 2023Talaris Therapeutics Inc Nasdaq TALS Talaris and Tourmaline Bio Inc Tourmaline a latestage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with lifealtering immune diseases today announ...
Calliditas Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Full Approval of TARPEYO®
Thursday, June 22, 2023Calliditas Therapeutics AB Nasdaq CALT Nasdaq Stockholm CALTX Calliditas today announced the submission of a supplemental New Drug Application sNDA to the US Food and Drug Administration FDA seeking full approval of TARPEYO budesonide delayed release...
Ozette Technologies Announces New Collaboration with Umoja Biopharma to Accelerate Biomarker Discovery in Preclinical Studies
Thursday, June 22, 2023Ozette Technologies Inc a technologydriven life sciences company today announced its collaboration with Umoja Biopharma Inc a transformative immunooncology company creating offtheshelf treatments for solid and hematologic cancers Umoja will use Ozett...
